Karen J. Goddard, MD MRCP FRCPC MA
University of British Columbia (UBC)
Active Staff: Radiation Oncologist
British Columbia Cancer Agency (BCCA) – Vancouver Centre *
Active Clinical Staff B.C. Children’s Hospital
Medical Director of the Adult Childhood Cancer Survivorship Program (BCCA – Provincial Program) *
Chair Provincial Sarcoma Tumor Group *
Health Authority: Provincial Health Services
600 West 10th Avenue
Vancouver, BC V5Z 4E6
Phone: 604.877.6000 Fax: 604.877.0505
Major Clinical Focus –
• Survivorship and long-term health problems in adult survivors of childhood cancer
• Sarcoma therapy
• Pediatric radiation oncology
• Pediatric Oncology Education
• Medical Doctor (Medicine), University of Manchester, Manchester, United Kingdom
• Bachelor of Science, University of St. Andrews, St Andrews, United Kingdom
• Master of Arts in Medicine and Law, University of British Columbia Interdisciplinary Graduate Studies Program
• Fellow (Fellowship in Paediatric Radiation Oncology), Toronto Bayview Cancer Centre, Toronto, Ontario, Canada, 1988-1989
• Fellow of The Royal College of Physicians of Canada (Radiation Oncology), Royal College of Physicians & Surgeons of Canada, Canada, 1988
Biographic Summary ( Background, Academic Interests and Activities, Clinical Activities )
Karen Goddard is a clinical radiation oncologist at the BC Cancer Agency. She is the medical director of the Adult Childhood Cancer Survivorship Program and the Chair of the Provincial Sarcoma Tumor Group. Her special interests include survivorship, long-term health problems in adult survivors of childhood cancer, the management of soft tissue and bone sarcomas, pediatric radiation oncology, pediatric oncology education and health law.
She is a member of the Children’s Oncology Group and the Pediatric Radiation Oncology Society. She graduated from the UBC Interdisciplinary Graduate Studies Program in May 2014 with a MA in medicine and law. She is also editor in chief of the educational website www.pedsoncologyeducation.com
(Ten most recent selected peer-reviewed publications – Selected from 2014 – 2017)
1. Hasan, H., Howard, A.F., Metzger, D.L., Gill S., Johnson M., Lo, A., & Goddard K. Canadian endocrinologists’ views on growth hormone replacement therapy in adult survivors of pediatric brain tumors following achievement of final height. British Columbia Medical Journal, 2014:56(5):230-235.
2. Howard, A.F., Hasan, H., Bobinski, M.A., Nurcombe, W., Olson, R., Parkinson, M., & Goddard K. Educational Attainment, Discrimination and Bullying Experienced by Pediatric Brain Tumor Survivors: Parents’ Perspectives. Journal of Cancer Survivorship (Impact Factor: 3.3). 02/2014; 8(3). DOI: 10.1007/s11764-013-0331-5.
3. Hamilton, SN. Hasan, H. Parsons, C. Tyldesley, S. Howard, A. Bobinski, MA. Goddard K. Canadian Radiation Oncologists’ Opinions Regarding Peer Review – A National Survey. Practical Radiation Oncology. 2014 July 23 [Epub ahead of print]. DOI 10.1016/j.prro.2014.06.002..
4. Goddard K. Metabolic Syndrome, the risk of Cardiovascular Disease, Physical Activity and Childhood Cancer Survivors. Pediatr Blood Cancer Vol 62, Issue 2, start page 188 AID MPO25321. Published on line 22nd December 2014. DOI: 10.1002/pbc.25321.
5. Goddard K. Registries and Paediatric Radiation Oncology. J Med Imaging Radiat Oncol. 2014 Dec;58(6):691-2. doi: 10.1111/1754-9485.12253.
6. Hamilton, S. Carlson, R. Hasan, H. Rassekh, S. Goddard K. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma. Am J Clin Oncol. 2015 Jan 16. [Epub ahead of print].
7. Hasan, H. Hendson, G. Howard, A.F Hukin, J. Dunham, C Ahmed, T Lo, A, Goddard K. Assessing the accuracy of death records and pre-mortem clinical diagnoses in children diagnosed with brain tumors: A retrospective chart review of children in British Columbia, Canada. Pathol Res Pract. 2015 Oct;211(10):748-53. doi: 10.1016/j.prp.2015.06.008. Epub 2015 Jun 23.
8. Hasan, H., Howard A.F, Alassiri A.H, Ng T, L, McGregor, G. & Goddard K. “PEComa of the terminal ileum mesentery as a secondary tumour in an adult survivor of embryonal rhabdomyosarcoma.” Current Oncology [Online], 22.5 (2015): e383-e386. Web. 20 Oct. 2015.
9. Lo A, Howard FA, Nichol A, Hasan H, Martin MA, Heran M, Goddard K, A cross-sectional cohort study of cerebrovascular disease after radiation therapy for craniopharyngioma. Pediatr Blood Cancer. 2016 May; 63(5):786-93. doi: 10.1002/pbc.25889.
10. Hasan H, Shaikh OM, Rassekh SR, Howard AF, Goddard K, Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review. Pediatr Blood Cancer. 2017 Jan;64(1):81-88. doi: 10.1002/pbc.26200. Epub 2016 Aug 31.
* The British Columbia Cancer Agency (BCCA)-Vancouver Centre (VC) is the largest academic cancer centre for the BCCA, located in downtown Vancouver and treating about one third of the radiation oncology cancer patients in the Province of BC. Over 4360 cancer patients are seen each year in the radiation oncology department. There are 20 Radiation Oncology (RO) physician faculty with full disease site specialization and clinical programs of excellence, 2 General Practice (Internist) Oncology Physicians, 3 Clinical Fellows and 10 RO residents. The BCCA-Vancouver Centre also has 17 physicists and a graduate training program in physics, 15 nurses, >60 radiation therapists clerks, secretaries and many others within radiation oncology. General capabilities include 9 Linacs (including Truebeam), 1 cobalt, VMAT (first developed in the BCCA-VC), IMRT, SBRT, IGRT, HDR and LDR brachytherapy suites, and Protons (at the TRIUMF centre). The Vancouver Centre radiation oncology department conducts all levels of research (basic, translational, clinical, population), and is the main educational institution in BC for the training of graduate (residents) and undergraduate (medical) students. The interdisciplinary Radiation Oncology team is part of the even larger multidisciplinary and provincial teams.